One Stop Shop for All Your Market Research Reports

Global Non-Sterile Compounding Pharmacy Market 2018 Industry Research Report

This report focuses on the global Non-Sterile Compounding Pharmacy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Sterile Compounding Pharmacy development in United States, Europe and China. Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsterile" designation, making customized dosages according to legal and professional standards requires adhering to strict rules for ensuring and maintaining active pharmaceutical ingredient purity and potency; ensuring the accuracy of mixing; providing proper packaging, storage, and labeling; and keeping all work surfaces and equipment as clean as possible. Simple nonsterile compounding involves mixing medications according to established formulas, or "recipes," and creating liquid versions of drugs usually sold only as tablets or capsules. Pediatricians and veterinarians often request these kinds of products for babies and animals who cannot swallow pills or need doses smaller than ones in commercially produced products. Moderate nonsterile compounding involves making dosages containing potentially harmful medications or preparations that require special handling. In 2017, the global Non-Sterile Compounding Pharmacy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Fagron B.Braun Melsungen Fresenius Kabi True Nature Holding Dougherty's Pharmacy Pharmedium ... Market segment by Type, the product can be split into Oral Medication Topical Medications Otologic/Nasal Medication Market segment by Application, split into Pain Management Hormone Replacement Therapy Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Non-Sterile Compounding Pharmacy status, future forecast, growth opportunity, key market and key players. To present the Non-Sterile Compounding Pharmacy development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Non-Sterile Compounding Pharmacy are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Non-Sterile Compounding Pharmacy Market Size Growth Rate by Type (2013-2025) 1.4.2 Oral Medication 1.4.3 Topical Medications 1.4.4 Otologic/Nasal Medication 1.5 Market by Application 1.5.1 G
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Corporate User US $7800
About this Report
Report ID 297794
Category
  • Medical Devices
Published on 30-Aug
Number of Pages 98
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(28)